The Department of Veterans Affairs has selected Abridge for a new enterprise ambient AI scribe contract, with the multiple-award deal carrying a total ceiling of $775.72 million over five years across all vendors eligible to compete for individual task orders, according to a September 22 contract release. The award lets VA medical centers and regional networks nationwide bring Abridge’s AI scribe technology to their clinicians, continuing a rollout that has already reached dozens of VA sites.
What the contract actually covers
Rather than a single fixed-price deal, the VA structured this as a multiple-award contract, meaning several vendors — including Abridge and a company called Knowtex — remain eligible to compete for task orders as individual VA facilities and regional networks decide to adopt the technology. Abridge describes its ambient scribe as the only one in the running that integrates with both the VA’s legacy electronic health record systems and its newer EHR platforms, a distinction the company says matters given the VA’s long and uneven transition between record systems across its medical centers.
How far the rollout has already reached
Abridge says its ambient scribe technology is currently deployed at more than 70 VA medical centers, following a phased expansion that began with pilot programs. The Veterans Health Administration reported earlier this year that it had deployed ambient scribe tools to all VA Patient Aligned Care Team primary care providers, after an initial rollout phase covering 10 medical centers. That staged approach — starting with a limited pilot group before expanding system-wide — reflects a cautious rollout strategy common across large government health systems adopting AI tools for the first time.
The burnout problem driving adoption
Ambient AI scribes are designed to listen to patient visits and automatically generate clinical notes, reducing the hours physicians spend on documentation after their shifts end — a widely cited driver of burnout among VA providers managing heavy caseloads. VA pilot data reportedly indicate that veterans report better experiences with care when their provider uses an ambient scribe during appointments, according to agency officials, lending the technology political and administrative momentum inside an agency that has faced persistent provider shortages and high clinician turnover in recent years.
A competing study complicates the picture
Not all internal VA evidence points the same direction. A separate VHA-funded study found that AI-generated clinical notes scored lower on measures of quality compared with notes written by human providers, a finding that cuts against the broader narrative of ambient AI as an unambiguous improvement. The VA has not published its own comprehensive note-quality data alongside the new contract announcement, leaving outside observers to weigh vendor claims about adoption and satisfaction against that less favorable internal research when assessing how well the technology performs in practice.
Why this differs from Abridge’s commercial deals
Abridge has built a significant presence in the private hospital sector, including partnerships with major health systems and backing from pharmaceutical companies interested in the data its scribe technology generates during patient visits. The VA contract is distinct in scale and structure: government health IT contracts of this size typically unfold through task orders issued over years rather than upfront lump-sum payments, meaning the $775.72 million ceiling represents a maximum potential value across every participating vendor rather than a guaranteed revenue figure for any single company, including Abridge. How much of that ceiling actually gets spent will depend on how aggressively individual VA facilities move to adopt the technology over the life of the contract.
What to watch as the rollout continues
The VA has signaled it will continue expanding ambient scribe access gradually rather than mandating system-wide adoption all at once, following what officials have described as successful earlier pilots. Future scrutiny will likely focus on whether the agency publishes its own note-quality and clinician-satisfaction data as deployment broadens beyond the current roughly 70 sites, and on how the multi-vendor structure plays out in practice as facilities choose between Abridge, Knowtex, and any other qualified vendors competing for task orders under the new ceiling.
Congressional oversight of VA technology spending has intensified in recent years following several high-profile IT contracting setbacks at the agency, meaning lawmakers on veterans’ affairs committees are likely to ask pointed questions about cost controls and measurable outcomes as task orders begin flowing under the new ceiling. Abridge, for its part, has pointed to its existing commercial health-system relationships as evidence that its technology has already been tested at scale outside the government context, an argument the company has used to differentiate itself from vendors with less extensive deployment history. Whether that commercial track record translates smoothly into the VA’s more bureaucratic procurement and compliance environment remains one of the more consequential open questions as the rollout proceeds through its first full year under the new contract structure.
Photo: RDNE Stock project / PEXELS via Pexels
